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Abstract 
Background: Placenta accreta spectrum (PAS) 
has become a global problem secondary to the 
high rate of cesarean delivery (CD). The current 
study presents an effective surgical procedure 
(placental pouch closure) for uterine preservation 
in patients with PAS. 
Methods: We applied this procedure in sixty 
cases at a tertiary university hospital between 
September 2017 and January 2019. We included 
women who were diagnosed as PAS based on 
preoperative ultrasound and Doppler evaluation, 
and who had the desire for uterine preservation.  
Results: The procedure was successful in almost 
all cases; the uterus was conserved 98.33 % of 
participants, with no associated severe maternal 
morbidities or mortality. In all cases, no additional 
surgical procedures were needed. The mean 
blood loss was 1263 ml, and the mean number of 
units of blood required for transfusion was 2.31 
units.  
Conclusion: Identifying and meticulously closing 
the placental pouch is a novel surgical procedure 
for conservative management of PAS. In well-
selected cases with the availability of facilities 
and expertise, the technique could have a place 
as a safe and effective surgical technique in 
women presenting with placenta accreta who 
desire uterine preservation. 
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Introduction 
Placenta accreta spectrum (PAS) is a 
new term used to describe the clinical 
condition when part or the entirety of the 
placenta becomes abnormally adherent 
or invades the myometrium.1 The 
incidence of PAS has increased and 
seems to parallel the increasing 
cesarean delivery (CD) rate. 
Researchers have reported the 
incidence of PAS as 1 in 533 
pregnancies for the period of 1982–
2002.2 Women at greatest risk of PAS 
are those who have myometrial damage 
caused by a previous CD with either 
anterior or posterior placenta previa 
overlying the uterine scar.3 
Limited data exist to guide the optimal 
conservative management of this 
condition. The existing literature consists 
predominately of case reports, and 
studies undertaken using a retrospective 
review of medical records in a single 
hospital or at a small number of tertiary-
care institutions.4,5 
When considering an ideal treatment for 
PAS, one might consider hysterectomy 
as it is thought to be associated with 
decreased maternal morbidity and 
mortality. However, hysterectomy is, in 
fact, inappropriate as it ignores requests 
to conserve the patient’s uterus and 
preserve her fertility, thereby violating 
both surgical principals and the patient’s 
rights.  
Assiut University Women’s Health 
Hospital is a tertiary referral hospital in 
Upper Egypt with about 20,000 deliveries 
each year. It is also a referral hospital for 
high risk and complicated cases from the 
five main governorates of Upper Egypt. 
The hospital is well equipped and has 
more than 60 University staff members in 
Obstetrics and Gynecology, with a 
dedicated placenta accreta team.6 
The elective delivery of women with PAS 
should be managed by a multidisciplinary 
team, which should include senior 
anesthetists, obstetricians, and 
gynecologists with appropriate 
experience in managing this condition 
and other surgical specialties 
(interventional radiology, vascular 
surgery) if indicated, who have access to 
a blood bank and a well-equipped ICU. In 
an emergency, the most senior clinicians 
available should be involved.7 
The main aim of any surgical 
management strategy for placenta 
accreta is to decrease the risks of severe 
maternal morbidity during cesarean 
delivery.8-11 Successful conservative 
management strategies will also 
preserve fertility and thus reduce the 
impact on a woman’s societal status and 
the loss of self-esteem that is often 
associated with the loss of a uterus. 
In this article, we present our novel 
surgical procedure (placental pouch 
closure) for uterine preservation in 
patients with PAS. 
Patients and Methods 
Patients 
Sixty patients were enrolled between 
September 2017 and January 2019 at 
our tertiary university hospital. Written 
informed consent to participate in the 
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study, including the possibility of a 
hysterectomy, was obtained from each 
patient.  
The inclusion criteria included diagnosis 
of PAS based on preoperative ultrasound 
and Doppler evaluation, willingness to be 
electively scheduled for surgery and a 
desire to conserve their uteri. We 
excluded emergency cases including 
those in active labor or those with vaginal 
bleedin, both of which necessitate 
immediate intervention,  as well as those 
with known bleeding disorders or on 
anticoagulant therapy. 
A detailed history including maternal age, 
parity, duration of marriage, number of 
previous CD, and gestational age was 
taken by a study investigator. Pre-
surgical evaluation included the use of 
two-dimensional ultrasound to detect the 
site of the placenta and to determine the 
type of placenta previa, lacunae grade 
and myometrial thickening. In addition, 
color Doppler imaging was used to detect 
bridging vessels (abnormal vasculature 
that bridges from the placental mass to 
the uterine-bladder interface). 
Ultrasound and Doppler evaluations 
were performed by an expert level III 
sonographer in the Advanced Ultrasound 
unit of our institution. Preoperative 
investigations were performed, and at 
least four units of cross-matched whole 
blood or packed red blood cells (RBCs) 
were readied. 
Surgical procedure 
All surgeries were performed by the 
same obstetrician (K. M. Zahran) 
assisted by one assistant lecturer and at 
least one resident. All operative 
procedures were done under spinal 
anesthesia. While patients were in a 
sitting position, a subarachnoid block 
was performed with a 25 g pencil-point 
needle at the level of L 3-4 or L 4-5 
vertebral interspaces. Heavy 
bupivacaine 0.5%, at a rate of 10-12.5 
mg, and 0.3 mg morphine sulfate were 
injected intrathecally. After doing a wide 
Pfannenstiel incision, the bladder was 
carefully and extensively dissected from 
the lower uterine segment to avoid injury 
during removal of the placenta or repair 
of the uterus. Incision of the uterus was 
done transversely at the presumed upper 
edge of the placenta to avoid cutting 
through the placenta. After uterine 
incision, the fetus was delivered.  
In all cases, the uterus was exteriorized 
to allow for a good exposure. Saline 
containing 30 IU of oxytocin was run over 
the course of several minutes, and the 
uterus was continuously massaged to 
minimize bleeding and give time for 
placental separation. Then, the placenta 
was separated, starting from above 
downward, waiting to separate the most 
adherent parts until last to keep blood 
loss as low as possible. After separation, 
all placental fragments were extracted. 
The placental bed was then compressed 
with towels, the cervix was located and a 
catheter was inserted in the cervix from 
above downwards to allow identification 
of the cervical canal and avoid accidental 
closure of the cervix during repair of the 
placental pouch.  
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Figure 1: Placenta pouch splitting the uterine wall into two layers, anterior and 
posterior with clear delineation of its boundaries by the applied Allis's forceps. 
 
A crucial step was identifying the 
placental pouch followed by application 
of multiple Allis’s forceps to its edges 
(Figure 1). Meticulous closing of the 
placental pouch was performed by 
continuous running mass sutures, 
starting from the deepest point up, 
including more than one layer if needed 
(Figure 2). During this process, it was 
important to maintain the uterus 
contracted and to check for vaginal 
bleeding. After hemostasis was 
ascertained, closure of the cesarean 
incision in double layers was followed by 
regular closure steps for the laparotomy 
incision.  
Follow up 
All patients were kept under close 
monitoring for 24 hours post-operative 
with proper fluid and blood replacement 
and regular checks of vital signs, vaginal 
bleeding, and the amount of collected 
blood in intraperitoneal drains, if present. 
Hemoglobin level was re-checked 24 
hours post-operative.  
Statistical analysis 
All data were analyzed using Microsoft 
Excel, 2016. The results were expressed 
as mean±SD (minimum, maximum) for 
quantitative data or frequencies 
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(percentages) for qualitative data.  
 
Figure 2: Placenta pouch delineated during surgery. 
Results 
Table 1 summarizes the demographic 
data of all study participants. The mean 
age of the included cases was 30.13 
years, parity was 3.06, the mean number 
of previous CD was 2.6, and the 
gestational age at planned delivery was 
37.35 weeks. The mean preoperative 
hemoglobin level was 11.71gm/dl.  
Table 1: The demographic and clinical data of the study participants (n=60). 
Variables Mean Standard deviation Minimum Maximum 
Age (years) 30.13 4.52 23 43 
Parity 3.06 1.274 1 7 
Number of cesarean sections 2.59 1.09 1 5 
Gestational age at time of delivery (weeks) 37.35 1.09 34 39 
Preoperative hemoglobin level (gm/dl) 11.71 0.89 10 13 
Preoperative hematocrit value 33.41 1.787 30 39 
 
After delivery of the fetus, the placenta 
was found to be focally adherent in 33 
cases (55%) and totally adherent in 27 
cases (45%). The mean blood loss was 
nearly 1263 ml (range from 930 to 1600 
ml). The mean number of units of blood 
required for transfusion was 2.31 units. 
The duration of the procedure for 
placental pouch closure ranged between 
3 and 13 minutes depending on the size 
of the pouch (Table 2).  
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Table 2: The operative data of the study participants (n=60). 
Variables Mean Standard 
deviation 
Minimum Maximum 
IV oxytocin units 23.85 4.91 20 30 
Blood transfusion (units) 2.31 0.82 1 4 
Amount of blood loss (ml) 1263 160.92 930 1600 
Duration of cesarean section (minutes) 75.12 9.11 55 90 
Duration of placental pouch closure (minutes) 7.13 2.161 3 13 
Postoperative hemoglobin level (gm/dl) 10.63 0.67 9 12 
Postoperative hematocrit 30.77 1.04 27 34 
 
Intra-operatively, marked bladder 
adhesions were found in 40 cases 
(66.7%); however, no cases of bladder 
injuries were recorded. The current 
procedure was feasible in all cases. We 
did not utilize any surgical techniques to 
control bleeding other than closure of the 
placental bed or pouch. In 59 out of the 
60 enrolled cases, the uterus was 
successfully conserved. There were no 
cases of maternal mortality or severe 
morbidities related to the procedure.  
Regarding the perinatal outcome, the 
mean birth weight was 2.9±0.3 kg, the 
mean Apgar score at 5 minutes was 
9.73± 0.07 and no babies were referred 
to neonatal intensive care unit. 
Postoperative recovery was uneventful. 
Only one case (case No. 53) developed 
postoperative pelvic hematoma and 
hypotension for which immediate 
laparotomy re-exploration and 
hysterectomy were done. The patient 
was subsequently admitted to the 
intensive care unit for two days and 
discharged from the hospital three days 
later.  
The mean postoperative hemoglobin 
level was 10.15 gm/dl. The mean 
duration of postoperative hospital stay 
was 3.2 days 
Discussion 
In this article, we propose a novel 
technique for conservative management 
of the uterus in women with PAS who 
desire uterine preservation. 
Conservative management, including 
both abnormally adherent placenta 
(placenta accreta) and invasive placenta 
(placenta increta and percreta), defines 
all procedures that aim to avoid 
peripartum hysterectomy and its related 
morbidity and consequences. Four 
different primary methods of 
conservative management have been 
described in the international literature: 
(1) the extirpative technique in which the 
placenta is manually removed; (2) the 
expectant approach, which leaves the 
placenta in situ; (3) one-step 
conservative surgery, involving removal 
of the accreta area); and (4) the Triple-P 
procedure, which involves suturing 
around the accreta area after resection. 
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These methods have been used alone or 
in combination, often with additional 
procedures proposed by interventional 
radiology.12  
Several suture techniques have been 
used in the lower uterine segment to 
control hemorrhage during CD for 
placenta previa or PAS including Cho's 
hemostatic suturing technique, Hwu's 
parallel vertical compression sutures, 
circular isthmic-cervical sutures and 
Yan's folding sutures. 13-16 However, 
each of these techniques creates some 
difficulties and disadvantages during the 
operation. Additionally, their use has only 
been reported in a small case series with 
no further studies about their efficacy.  
We avoided manual removal of the 
placenta to prevent leaving any retained 
placental tissues in the uterine cavity. 
This is recommended in several 
guidelines as one of the key steps for 
management of postpartum 
hemorrhage.17-24 Manual removal of the 
placenta in cases of PAS should be 
avoided because forcibly removing an 
invasive placenta with placental villi that 
have invaded the deep uterine 
vasculature increases the risks of severe 
obstetric hemorrhage and the need for 
urgent hysterectomy.25 Severe bleeding 
will lead to coagulopathy with increased 
risk of bladder and ureteric injuries that 
can lead to long-term complications such 
as vesicouterine fistula.8-11  
In our series, we always started placental 
separation after waiting for the placenta 
to spontaneously separate. Once this 
had occurred, we started manual 
removal of the adherent or invasive parts 
at the end, which resulted in a dramatic 
decrease in blood loss without any 
bladder or ureteric injuries. This is logical 
as our technique of placental pouch 
closure starts with careful, meticulous 
and downward dissection of the bladder 
from the uterus before incising the 
uterus, which was an integral step in our 
methodology as mentioned above.   
The core principle of this procedure was 
based on our observation that, in many 
PAS patients, there was a pouch at the 
site of placental attachment that 
represented the dead space left inside 
the myometrium after its invasion by the 
placenta (in cases of increta variants of 
PAS). This pouch was the main source of 
bleeding after placental separation. After 
delineating the boundaries of this pouch 
using Allis’s forceps, we also noticed that 
the bottom of the pouch was not the 
cervical canal, as we had thought before, 
and that the cervical canal was situated 
posterior to this pouch.  
Taking this observation into 
consideration when dealing with PAS, we 
put a catheter in the cervical canal, and 
we looked for the placental pouch at its 
origin points for most of the bleeding 
coming from inside the cervix. Thus, we 
were able to close this bed with stitches 
without having to worry about the 
constant risk of closing the cervical canal.  
In 2018, the Green-top guideline 
advocated conservative management of 
PAS and reported that when the invasion 
of placental tissue inside the myometrium 
is limited in its extent and the entire 
placental invasion area is accessible 
when visualized, conservation of the 
uterus may be applicable, including 
partial myometrial resection.26. 
Proceedings in Obstetrics and Gynecology, 2020;9(3):6 
 
 
Placental pouch closure in PAS  8 
 
Furthermore, they reinforced that 
conservative techniques should only be 
undertaken by experienced surgical 
teams who can efficiently manage such 
cases after counseling the patients and 
collecting their written consent.2 
In this study, we opened the uterus 
immediately above the presumed upper 
placental edge; this allowed us to easily 
control bleeding from the placental pouch 
as the target area of the bleeding 
became more accessible. This coincides 
with the 2018 FIGO consensus 
guidelines on PAS disorders, which state 
that preoperative ultrasound mapping of 
the placental site in cases of invasive 
PAS disorders should be used to 
determine the site of incision.12 
In this study, we noticed that there was a 
dramatic reduction of severe morbiduty 
and mortalities resulting from our focus 
on placenta accreta. We operated on 60 
cases with a variable degree of PAS. The 
procedure was successful in almost all 
cases; the uterus was conserved in 98.33 
% of them, and there were no associated 
severe maternal morbidities or mortality. 
In this study, all operations were carried 
out under spinal anesthesia with 
intrathecal morphine. We used regional 
anesthesia in order to have time for 
careful and meticulous bladder 
dissection without fear of fetal asphyxia. 
Since intrathecal morphine is 
hypotensive anesthesia and has no 
effect on the tone of the uterus 
throughout surgery, it resulted in less 
intraoperative blood loss. In addition, it 
provided excellent postoperative pain 
relief. 
Another technical difficulty that faced us 
when discussing all surgical techniques 
for management of PAS was the high 
rate of bladder injury due to extensive 
adhesion resulting from repeated 
cesarean deliveries and which mandate 
urologic consultation and bladder repair. 
This could lead to prolongation of the 
operative time in critically ill patients. To 
overcome this difficulty, we carefully and 
extensively dissected the bladder from 
the anterior uterine segment before 
performing the uterine incision, taking 
advantage of the distended lower uterine 
segment and the easier identification of 
surgical planes before uterine incision.  
In June 2019, FIGO released a clinical 
grading system to assess and categorize 
placental adherence or invasion at 
delivery27. Our technique could be 
effective in grades 1 and 2. 
The limitations of the current technique 
include considerable placental bed 
bleeding. If the technique we used were 
modified by adding some steps that could 
result in decreased blood loss, the 
technique could be mastered by a wider 
range of skilled obstetricians. Secondly, 
the technique also needs to be modified 
to reduce bleeding from the back of the 
bladder due to extensive bladder 
dissection from the lower uterine 
segment, which is a crucial step in this 
technique. Regarding the generalizability 
of the technique, since we began this 
project, many of our colleagues have 
mastered the technique with excellent 
results. The learning curve of the 
technique has been consistently 
shortening, as reflected by a gradual 
decrease in both the amount of blood lost 
and the need for blood transfusions over 
time. Finally, the issue of patient consent 
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needs careful consideration. In general, 
women, particularly in Egypt, want to 
avoid cesarean hysterectomy and 
preserve fertility – even after as many as 
five C-sections. However, they lack 
evidence-based information about truly 
invasive PAS, including the 10 – 20% risk 
of uterine rupture and the effects of PAS 
in subsequent pregnancies.  We include 
the risks of PAS and uterine rupture in 
the consent form that patients sign prior 
to the onset of treatment.  
Conclusions 
As a result of this study, we are able to 
present a new, standardized, and 
effective procedure that reduces 
maternal morbidity and mortality while 
still allowing for uterine preservation in 
women with PAS who desire future 
fertility. In well-selected cases with the 
availability of facilities and expertise, the 
technique could have a place as a safe 
and effective surgical technique for 
uterine preservation in cases of PAS. 
Future studies should be carried out to 
compare this procedure with other 
conservative techniques for 
management of PAS. Currently, we are 
working on comparing our technique with 
other surgical techniques for 
conservative management of PAS that 
have been used at our hospital. 
Additionally, studies to evaluate the 
uterine cavity and the effect of the 
procedure on the fertility outcomes 
should be conducted. 
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